Armata Pharmaceuticals (ARMP) Market Capitalization (2013 - 2026)

Armata Pharmaceuticals has disclosed Market Capitalization across 14 years of filings, most recently posting $240.7 million for Q2 2026.

• In Q2 2026, Market Capitalization rose 250.03% year-over-year to $240.7 million; the TTM figure through Jun 2026 stood at $240.7 million (up 250.03% YoY), while the FY2025 annual figure was $228.8 million, up 241.79% from the prior year.
• Market Capitalization came in at $240.7 million for Q2 2026 at Armata Pharmaceuticals, down from $375.2 million in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $375.2 million in Q1 2026 to a low of $41.2 million in Q2 2023.
• Average Market Capitalization over 5 years is $127.0 million, with a median of $108.8 million recorded in 2023.
• Year-over-year, Market Capitalization sank 70.69% in 2023 and jumped 610.11% in 2026.
• Over 5 years, Market Capitalization stood at $44.8 million in 2022, then soared by 161.13% to $117.0 million in 2023, then plunged by 42.81% to $66.9 million in 2024, then jumped by 241.79% to $228.8 million in 2025, then rose by 5.21% to $240.7 million in 2026.
• Per Business Quant data, the three most recent Market Capitalization figures were $240.7 million in Q2 2026, $375.2 million in Q1 2026, and $228.8 million in Q4 2025.